ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 12,746 shares, the number of shares held increased 0.59% compared to the previous period and now represents 5.26% of the total position.
      227Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 8,843 shares, the number of shares held decreased 2.13% compared to the previous period and now represents 2.8% of the total position.
      129Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 12,846 shares, the number of shares held increased 0.43% compared to the previous period and now represents 2.36% of the total position.
      64Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 4,627 shares, the number of shares held increased 0.22% compared to the previous period and now represents 5.94% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Cleared position in Atai Beckley Inc by 3,169,573 shares, the number of shares held decreased 100% compared to the previous period and now represents 0% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·01-02 07:13
      ARKG Investment Tracker position change: Increased position in Veeva by 48 shares, the number of shares held increased 0.12% compared to the previous period and now represents 0.76% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·01-02 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 71,574 shares, the number of shares held increased 0.67% compared to the previous period and now represents 1.6% of the total position.
      5.94K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·01-02 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 5,956 shares, the number of shares held increased 0.12% compared to the previous period and now represents 1.42% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·01-02 07:13
      ARKG Investment Tracker position change: Increased position in Atai Beckley Inc by 3,942 shares, the number of shares held increased 0.12% compared to the previous period and now represents 1.09% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·01-02 07:13
      ARKG Investment Tracker position change: Increased position in Illumina by 496 shares, the number of shares held increased 0.12% compared to the previous period and now represents 4.57% of the total position.
      0Comment
      Report
     
     
     
     

    Most Discussed